05-Dec-2019
The prevalence of dental diseases, such as dental caries and gum disease, is increasing worldwide. CBCT scans are used to diagnose these diseases early and help prevent more serious complications. This factor is expected to propel the growth of CBCT during the forecast period.
The Cone-Beam Computed Tomography (CBCT) Systems Market is valued at USD 1.34 billion in 2022, and is expected to reach USD 3.45 billion by 2030, with a CAGR of 11.7% from 2023 to 2030, according to new research by Next Move Strategy Consulting.
The aging population is rising. According to the report published by the World Health Organization, the number of people above the age of 60 years reached 1.4 billion in 2020 in October 2022. It is expected that the number will reach 2.1 billion by 2050. This aging population is highly anticipated to develop dental problems. As CBCT helps diagnose and treat these problems, it can improve the quality of life for older adults. This factor drives the expansion of the CBCT market.
On the contrary, the high cost of CBCT machines along with the installation, maintenance, and training costs act as restraining factors for the market growth. The average cost of CBCT machines ranges from USD 50000 to 100000. For example, Cefla S.C.'s supine CBCT is priced at USD 53,593.
However, the rising adoption of advanced technologies, such as artificial intelligence (AI) and augmented reality & virtual reality (AR/VR), for analyzing and interpreting images with greater precision and efficiency presents an opportunity for the market. These algorithms can be trained to automatically detect and segment anatomical structures, lesions, and abnormalities along with providing valuable insights to clinicians. By automating these tasks, AI integration can save time and improve diagnostic accuracy, ultimately leading to more effective treatment planning.
According to the report, leading players in the CBCT market include Dentsply Sirona, Koninklijke Philips N.V., Vatech Co., Ltd., Dexis LLC, Planmeca OY, J. Morita Mfg. Corp., Cefla S.C., Hefei Meyer Optoelectronic Technology, Inc., Xoran Technologies LLC, Acteon Group, and others.
These market players are adopting strategies such as collaboration and product launches across various regions to maintain their dominance in the CBCT market.
For instance, in May 2023, Carestream Dental collaborated with Glidewell to distribute their CBCT imaging systems in the U.S. The partnership aims to enhance patient access to advanced 3D imaging technology for a wider range of clinical procedures.
Also, in May 2023, Planmeca OY unveiled a range of innovative products at IDS 2023. The company showcased its latest advancements, including digital intraoral sensors, 2D and 3D imaging systems, dental chairs, CAD/CAM solutions, and software. These cutting-edge products aim to enhance the dental experience, improve diagnostic capabilities, and optimize workflow efficiency for dental professionals.
In March 2023, Osstem Implant introduced an improved version of its CBCT machine called the T2 Plus. This new product has advanced features that allow for better quality images with higher resolution than the previous T2 model.
In October 2022, LargeV Instrument Corp. Ltd. launched its innovative Ultra3D dual-source ENT CBCT system. This advanced medical imaging device received approval from the National Medical Products Administration (NMPA) in China. It can be used for X-ray inspections in ENT, stomatology, and maxillofacial surgery applications.
In October 2022, Dexis LLC launched its new intraoral scanning portfolio that includes three distinct scanning devices, each designed to cater to different clinical needs and preferences. These innovative intraoral scanners offer enhanced accuracy, ease of use, and advanced features. They enable dental professionals to streamline their workflows and deliver precise treatment planning and outcomes.
The information related to key drivers, restraints, and opportunities and their impact on the CBCT market is provided in the report.
The value chain analysis in the market study provides a clear picture of the role of each stakeholder.
The market share of the players in the global CBCT market along with their competitive analysis are provided in the report.
The increased prevalence of non-communicable diseases is dri...
Increasing healthcare investment is driving the Uruguay in-v...
The increased prevalence of chronical diseases is driving th...
This website uses cookies to ensure you get the best experience on our website. Learn more
✖